EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹394 Cr | ₹286 Cr | ₹97 Cr | ₹12 Cr | ₹13 Cr |
What is the latest Contingent Liabilities ratio of EMCURE PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹394 Cr |
| Mar2024 | ₹286 Cr |
| Mar2023 | ₹97 Cr |
| Mar2022 | ₹12 Cr |
| Mar2021 | ₹13 Cr |
How is Contingent Liabilities of EMCURE PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹394 Cr | 37.98 | |
| Mar2024 | ₹286 Cr | 194.49 | |
| Mar2023 | ₹97 Cr | 703.28 | |
| Mar2022 | ₹12 Cr | -5.66 | |
| Mar2021 | ₹13 Cr | - | |
Compare Contingent Liabilities of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹35,297.5 Cr | 2.8% | 6.2% | 37.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,382.0 Cr | 0.8% | 7.3% | 15.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,375.0 Cr | 1.9% | 8.2% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,308.0 Cr | 0.6% | 12.6% | 43.9% | Stock Analytics | |
| CIPLA | ₹116,447.0 Cr | 0.2% | 6.3% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,106.0 Cr | -1.8% | -3.5% | -3.4% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 2.8% |
6.2% |
37.6% |
| SENSEX | 0.1% |
0.7% |
-6.6% |
You may also like the below Video Courses